Presentation by Wolf Ondracek of CHDR and Promasys for the Science meets Business café of 16 May 2013. This event was held in the BioPartner Accelerator building in Leiden.
The Translational Medicine Ontology: Driving personalized medicine by br...Michel Dumontier
The Translational Medicine Ontology provides terminology that bridges diverse areas of translational medicine including hypothesis management, discovery research, drug development and formulation, clinical research, and clinical practice. Designed primarily from use cases, the ontology consists of essential terms that are mapped to other ontologies. It serves as a global schema for data integration while simultaneously facilitating the formulation of complex queries across heterogeneous sources. We demonstrate the utility of the ontology through question answering over a prototype knowledge base composed of sample patient data integrated with linked open data. This work forms a basis for the development of a computational platform for managing information relevant to personalized medicine.
tranSMART Community Meeting 5-7 Nov 13 - Session 1: Translational Drug Disco...David Peyruc
tranSMART Community Meeting 5-7 Nov 13 - Session 1:
Translational Drug Discovery - Transforming Science into Medicine
Current challenges in translational Drug Discovery at Sanofi R&D
Andy Plump, Sanofi
Development of Translational Medicine at Univ. of Medicine & Pharmacy (UMP), ...Thai Nguyen PeterTigr
UMP is now taking the new challenge in developing modern biomedical research to align our scientific programs with the international medical community, and importantly, to harness the advancements of biological sciences for medical services, via translational research, for unmet medical illnesses of the Vietnamese patients.
Writing medical content for clinical research quick guide for clinical practi...Medical Writing Experts
Medical content Writing is an integral component of clinical research that is essential for effectively taking research related scientific communications to the target audience like medical specialists and health care professionals.
Effective and well-structured medical contents with appropriate research design and reference support is imperative for every aspiring medical researcher to publish their clinical research studies in reputed national and international medical journals.
This medical content writing quick guide is intended to help the clinical practitioners and researchers understand the nuances of clinical research writing that will enable them to make effective clinical research paper presentations to their intended targeted audience.
Professional medical research help is available for health care professionals and researchers who have time, resources and writing skills constraints.
How to conduct high-quality clinical research?scanFOAM
A presentation by Anders Perner at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
The Translational Medicine Ontology: Driving personalized medicine by br...Michel Dumontier
The Translational Medicine Ontology provides terminology that bridges diverse areas of translational medicine including hypothesis management, discovery research, drug development and formulation, clinical research, and clinical practice. Designed primarily from use cases, the ontology consists of essential terms that are mapped to other ontologies. It serves as a global schema for data integration while simultaneously facilitating the formulation of complex queries across heterogeneous sources. We demonstrate the utility of the ontology through question answering over a prototype knowledge base composed of sample patient data integrated with linked open data. This work forms a basis for the development of a computational platform for managing information relevant to personalized medicine.
tranSMART Community Meeting 5-7 Nov 13 - Session 1: Translational Drug Disco...David Peyruc
tranSMART Community Meeting 5-7 Nov 13 - Session 1:
Translational Drug Discovery - Transforming Science into Medicine
Current challenges in translational Drug Discovery at Sanofi R&D
Andy Plump, Sanofi
Development of Translational Medicine at Univ. of Medicine & Pharmacy (UMP), ...Thai Nguyen PeterTigr
UMP is now taking the new challenge in developing modern biomedical research to align our scientific programs with the international medical community, and importantly, to harness the advancements of biological sciences for medical services, via translational research, for unmet medical illnesses of the Vietnamese patients.
Writing medical content for clinical research quick guide for clinical practi...Medical Writing Experts
Medical content Writing is an integral component of clinical research that is essential for effectively taking research related scientific communications to the target audience like medical specialists and health care professionals.
Effective and well-structured medical contents with appropriate research design and reference support is imperative for every aspiring medical researcher to publish their clinical research studies in reputed national and international medical journals.
This medical content writing quick guide is intended to help the clinical practitioners and researchers understand the nuances of clinical research writing that will enable them to make effective clinical research paper presentations to their intended targeted audience.
Professional medical research help is available for health care professionals and researchers who have time, resources and writing skills constraints.
How to conduct high-quality clinical research?scanFOAM
A presentation by Anders Perner at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
Traditional Medicine (TM) has been subject to substantial debate with regard to the ethics governing research in this area. The controversies have generally revolved around the unreasonable harvesting of medicinal plants, ethical accountability of researchers towards local knowledge holders and the credibility of TM as a complementary and alternative mode of treatment.
This presentation stresses the importance of understanding the 6 ethical principles governing publication in TM journals:-
1. Sustenance
2. Scientific validation
3. Informed consent
4. Reporting standards
5. Proprietary issues
6. Ethical policies and declarations
Prof. Todor (Ted) A. Popov - 6th Clinical Research ConferenceStarttech Ventures
Ομιλία - Παρουσίαση: Prof. Todor (Ted) A. Popov, Professor of Medicine, Medical University in Sofia, Chairman of the Bulgarian Ethics Committee for Multicenter Studies
Τίτλος Παρουσίασης: «Do databases around the world speak the same language?»
Clinical trials constitute a critical stage of clinical research and it is important to understand what clinical trials are and what forms they take. In this slide deck, we will tell you more about the types and phases of clinical trials.
Clinical trials constitute a critical stage of clinical research and it is important for you to understand what clinical trials are and what forms they take. In this slide deck, we will tell you more about the types and phases of clinical trials. The idea is to help you form a basic understanding of clinical trials. This is a two-part series and the next segment will focus on the things you must remember when preparing to publish a clinical trial manuscript.
Coming soon - Part 2: Things to remember when preparing a clinical trial manuscript
What’s next: The future of non-invasive neurotechnologySharpBrains
(Session held at the 2014 SharpBrains Virtual Summit; October 28-30th, 2014)
3-4pm. What’s next: The future of non-invasive neurotechnology
- Dr. Bruce Cuthbert, Director of Adult Translational Research and Treatment Development at the NIMH
- Charles Fisher, President of Fisher Wallace Laboratories
- Chair: James Cavuoto, Editor and Publisher at Neurotech Reports
Learn more here:
http://sharpbrains.com/summit-2014/agenda/
Traditional Medicine (TM) has been subject to substantial debate with regard to the ethics governing research in this area. The controversies have generally revolved around the unreasonable harvesting of medicinal plants, ethical accountability of researchers towards local knowledge holders and the credibility of TM as a complementary and alternative mode of treatment.
This presentation stresses the importance of understanding the 6 ethical principles governing publication in TM journals:-
1. Sustenance
2. Scientific validation
3. Informed consent
4. Reporting standards
5. Proprietary issues
6. Ethical policies and declarations
Prof. Todor (Ted) A. Popov - 6th Clinical Research ConferenceStarttech Ventures
Ομιλία - Παρουσίαση: Prof. Todor (Ted) A. Popov, Professor of Medicine, Medical University in Sofia, Chairman of the Bulgarian Ethics Committee for Multicenter Studies
Τίτλος Παρουσίασης: «Do databases around the world speak the same language?»
Clinical trials constitute a critical stage of clinical research and it is important to understand what clinical trials are and what forms they take. In this slide deck, we will tell you more about the types and phases of clinical trials.
Clinical trials constitute a critical stage of clinical research and it is important for you to understand what clinical trials are and what forms they take. In this slide deck, we will tell you more about the types and phases of clinical trials. The idea is to help you form a basic understanding of clinical trials. This is a two-part series and the next segment will focus on the things you must remember when preparing to publish a clinical trial manuscript.
Coming soon - Part 2: Things to remember when preparing a clinical trial manuscript
What’s next: The future of non-invasive neurotechnologySharpBrains
(Session held at the 2014 SharpBrains Virtual Summit; October 28-30th, 2014)
3-4pm. What’s next: The future of non-invasive neurotechnology
- Dr. Bruce Cuthbert, Director of Adult Translational Research and Treatment Development at the NIMH
- Charles Fisher, President of Fisher Wallace Laboratories
- Chair: James Cavuoto, Editor and Publisher at Neurotech Reports
Learn more here:
http://sharpbrains.com/summit-2014/agenda/
The term “research” refers to a class of activity designed to develop or contribute to generalizable knowledge. Generalizable knowledge consists of theories, principles, or relationships, or the accumulation of information on which they are based, that can be corroborated by accepted scientific methods of observation and inference. In the present context, “research” includes both medical and behavioral studies pertaining to human health. Usually “research” is modified by the adjective “biomedical” to indicate its relation to health.
What if we never agree on a common health information model?Koray Atalag
In this talk I will touch on some hard problems in health informatics around working with structured data and why we can’t link and reuse them with ease. The essence of the problem is that, while clinicians can perfectly understand each other, IT systems can’t. Traditional IT requires formally defined common terminology, meta-data, data and process definitions. While Medicine is mostly accepted as positive science, yet the great variation in the body of knowledge and practice is often seen as ‘Art’. Ignoring this bit, IT people tend to develop all-inclusive common information models (almost always too complex to implement) and expect everybody adhere to that. Clinicians love to do things a bit differently and of course don’t buy into that! Maybe they are right! Maybe we don’t have to agree on a uniform model at all. This is the basic assumption of the openEHR methodology which I will describe by giving clinical examples. The main premise of this approach is to effectively separate tasks of healthcare and technical professionals. Clinicians can easily define their information needs as they like using visual tools – called Archetypes which are essentially maximal data sets. These computable artefacts, built using a well defined set of technical building blocks, are then fed into the technical environment to integrate data or develop software. Lastly the free web based openEHR Clinical Knowledge Manager portal provides collaborative Archetype development and ensures semantic consistency among different models.
2015 09-14 Precision Medicine 2015, London, Alain van GoolAlain van Gool
Outline of my view hoe personalized health(care) is more than just targeted medicines, also including personal motivation and actions towards disease prevention. It also outlines 4 key factors that should be in order for optimal personalized health(care): 1. start with patients first, 2. Accelerate translation research to application, 3. Copy best practice, 4. Spread the word.
Personalized medicine tools for clinical trials - kuchinkeWolfgang Kuchinke
Tools for personalised medicine in clinical trials. ---------
The implementation of clinical trials in personalized medicine is a different way of doing clinical research compared to the standard way of large clinical trials aiming for statistical significance. Personalized medicine uses a medical model that separates people into different groups with medical decisions, practices, drugs, interventions being tailored to the individual patient based on their predicted response. Basis for this approach is the progress of the study of the human genome and its variation over the last two decades. Especially advancement in automated DNA sequencing and PCR and the use of expressed sequence tags (ESTs), cDNAs, antisense molecules, small nterfering RNAs (siRNAs), full-length genes and their expression products and haplotypes.
But adoption of personalized medicine requires an active and flexible and highly integrated infrastructure, which allows joining of many different competences and technologies. We asked the question: can the tools developed for personalized medicine in the p-pedicine project be employed effectively in a clinical trials network to support personalised clinical trials. We conducted an analysis of tool integration and the evaluation tool usage requirements. Based on the survey results, the tendency for clinical trial network ECRIN is to use software as a service in the form as SaaS or ASP. ECRIN data centres will (probably) not install and employ p-medicine tools in one of their data centres. A robust business model for the provision of services and the implementation and employment of tools does not yet exist.
How can the personalized medicine infrastructure p-medicine and the clinical trials network ECRIN gain from each other to allow the conduct of personalized clinical trials?
We suggest a business model, in which personal medicine infrastructures and clinical trials networks exchange their services to gain jointly from each other. Therefore: an integration by reciprocal exchange of services may be the solution. Not only software as a service will be exchanged, but also knowledge, personnel and joint staff trainings.
Personalized medicine tools for clinical trials - KuchinkeWolfgang Kuchinke
Tools for personalised medicine in clinical trials.
The implementation of clinical trials in personalized medicine is a different way of doing clinical research, compared to the standard way of large clinical trials aiming for statistical significance. Personalized medicine uses a medical model that separates people into different groups with medical decisions, practices, drugs, interventions being tailored to the individual patient based on their predicted response. Basis for this approach is the progress of the study of the human genome and its variation over the last two decades. Especially advancements in automated DNA sequencing, PCR technologies and the use of expressed sequence tags (ESTs), cDNAs, antisense molecules, small interfering RNAs (siRNAs).
But the adoption of personalized medicine requires an active and flexible and highly integrated infrastructure, which must allow the joining of many different competences and technologies. We asked the question: can the tools developed for personalized medicine in the p-pedicine project be employed effectively in a clinical trials network to support personalised clinical trials? We conducted an analysis of tool integration and the evaluation of tool usage requirements. Based on the survey results, the tendency for the clinical trial network ECRIN is to use software as a service in the form of SaaS or ASP. ECRIN data centres will (probably) not install and employ p-medicine tools in one of their data centres. A robust business model for the provision of services and the implementation and employment of tools does not yet exist.
How can the personalized medicine infrastructure p-medicine and the clinical trials network ECRIN gain from each other to allow the conduct of personalized clinical trials? We suggest a business model, in which personalized medicine infrastructures and clinical trials networks exchange their services to gain jointly from each other. An integration of networks by reciprocal exchange of services may be the solution. Not only software as a service will be exchanged, but also knowledge, personnel and staff trainings.
This is a lecture I wrote to introduce my students to the concept of Evidence Based medicine. Goes hand in hand with many handouts, such as the parachute study.
Special thanks to Dr. Brian Bledsoes lecture on EBM, from wich I pirated liberally.
Presentation by Marieke Hogervorst of Biomimiq for the Science meets Business café of 11 Dec 2014. This event was held in the BioPartner 1 foyer in Leiden. For the report, see http://www.sciencemeetsbusiness.nl/11-decy-2014/
Presentation by Nynke van den Berg, PhD candidate at the Interventional Molecular Imaging group at Radiology, LUMC, for the Science meets Business café of 9 October 2014. This event was held in the BioPartner 1 foyer in Leiden. For the report, see http://www.sciencemeetsbusiness.nl/9-oct-2014/
Presentation by Adalberto Costessi of Baseclear B.V. for the Science meets Business café of 8 May 2014. This event was held in the BioPartner 1 foyer in Leiden. For the report, see http://www.sciencemeetsbusiness.nl/8-may-2014/
SmB cafe 13 Mar '14 - Institute of Biology Leiden - Revolving fundChristiaan van Gorkum
Presentation by Laura Zondervan of the Institute of Biology Leiden for the Science meets Business café of 13 Mar 2014. This event was held in the BioPartner 1 foyer in Leiden. For the report, see http://www.sciencemeetsbusiness.nl/13-mar-2014/
SmB cafe 13 Mar '14 - Leiden Institute of Chemistry - Maturation facilityChristiaan van Gorkum
Presentation by Prof. Jaap Brouwer of the Leiden Institute of Chemistry for the Science meets Business café of 13 Mar 2014. This event was held in the BioPartner 1 foyer in Leiden. For the report, see http://www.sciencemeetsbusiness.nl/13-mar-2014/
Presentation by Kees Kluft of Good Biomarker Sciences for the Science meets Business café of 13 Feb 2014. This event was held in the BioPartner 1 foyer in Leiden. For the report, see http://www.sciencemeetsbusiness.nl/13-feb-2014/
Presentation by Sjaak Vink of MyTomorrows for the Science meets Business café of 13 Feb 2014. This event was held in the BioPartner 1 foyer in Leiden. For the report, see http://www.sciencemeetsbusiness.nl/13-feb-2014/
Results brainstorm session 12 Dec 2013 at Science meets Business caféChristiaan van Gorkum
The feedback worked out by Mark McDonnell for the Science meets Business café brainstorm session in the BioPartner 1 building. Topics introduced by mayor Henri Lenferink and brainstorm facilitated by Gert-Jan Cornel, Harmen Jousma, Karen Zimmermann and Hans LeFever.
SmB café brainstorm 12 Dec '13 - Living Lab voor Zorginnovaties - Gert-Jan Co...Christiaan van Gorkum
Presentation by Gert-Jan Cornel of Living Lab voor Zorginnovaties and Mark McDonnell of Inpaqt on 12 Dec 2013. This event was held in the BioPartner 1 foyer in Leiden.
SmB café brainstorm 12 Dec '13 - Living Lab voor Zorginnovaties - Gert-Jan Co...Christiaan van Gorkum
Presentation by Gert-Jan Cornel of Living Lab voor Zorginnovaties and Mark McDonnell of Inpaqt on 12 Dec 2013. This event was held in the BioPartner 1 foyer in Leiden.
Presentation by Sijme Zeilemaker of ToBBB for the Science meets Business café of 12 sep 2013. This event was held in the BioPartner Accelerator building in Leiden.
Presentation by Max Collon of Cosine for the Science meets Business café of 12 sep 2013. This event was held in the BioPartner Accelerator building in Leiden.
Presentation by Willem Hogeweg of Intellimagic for the Science meets Business café of 13 Jun 2013. This event was held in the BioPartner Accelerator building in Leiden.
Presentation by Alex Huyben of HALIX for the Science meets Business café of 13 Jun 2013. This event was held in the BioPartner Accelerator building in Leiden.
Presentation by Asad Hyder of Syntecnos for the Science meets Business café of 13 Jun 2013. This event was held in the BioPartner Accelerator building in Leiden.
Presentation by Heleen Willemsen of Babybloom for the Science meets Business café of 16 May 2013. This event was held in the BioPartner Accelerator building in Leiden.
Christiaan van Gorkum gave a presentation - based on earlier work by Science Based Business from Leiden University - on the history and development of the Leiden Bio Science Park and its companies.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
Unveiling the Secrets How Does Generative AI Work.pdfSam H
At its core, generative artificial intelligence relies on the concept of generative models, which serve as engines that churn out entirely new data resembling their training data. It is like a sculptor who has studied so many forms found in nature and then uses this knowledge to create sculptures from his imagination that have never been seen before anywhere else. If taken to cyberspace, gans work almost the same way.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraAvirahi City Dholera
The Tata Group, a titan of Indian industry, is making waves with its advanced talks with Taiwanese chipmakers Powerchip Semiconductor Manufacturing Corporation (PSMC) and UMC Group. The goal? Establishing a cutting-edge semiconductor fabrication unit (fab) in Dholera, Gujarat. This isn’t just any project; it’s a potential game changer for India’s chipmaking aspirations and a boon for investors seeking promising residential projects in dholera sir.
Visit : https://www.avirahi.com/blog/tata-group-dials-taiwan-for-its-chipmaking-ambition-in-gujarats-dholera/
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
LA HUG - Video Testimonials with Chynna Morgan - June 2024Lital Barkan
Have you ever heard that user-generated content or video testimonials can take your brand to the next level? We will explore how you can effectively use video testimonials to leverage and boost your sales, content strategy, and increase your CRM data.🤯
We will dig deeper into:
1. How to capture video testimonials that convert from your audience 🎥
2. How to leverage your testimonials to boost your sales 💲
3. How you can capture more CRM data to understand your audience better through video testimonials. 📊
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...BBPMedia1
Marvin neemt je in deze presentatie mee in de voordelen van non-endemic advertising op retail media netwerken. Hij brengt ook de uitdagingen in beeld die de markt op dit moment heeft op het gebied van retail media voor niet-leveranciers.
Retail media wordt gezien als het nieuwe advertising-medium en ook mediabureaus richten massaal retail media-afdelingen op. Merken die niet in de betreffende winkel liggen staan ook nog niet in de rij om op de retail media netwerken te adverteren. Marvin belicht de uitdagingen die er zijn om echt aansluiting te vinden op die markt van non-endemic advertising.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
2. CHDR: Unlocking the true potential…
• Established in 1987 as a not-for-profit foundation
• By Leiden University and LUMC
• Prof. Douwe Breimer & Prof. Adam Cohen
• Clinical research organization closely linked to top level universities
• Profits re-invested in biomarker and method development & education
• Contract Research for bio-pharmaceutical industry
• Focus on early phase clinical trials
• Data intensive, small number of subjects
• Proof of pharmacology
• Proof of concept
• Organization
• 160 employees (80 FTE)
• Dynamic & International environment
• Wolf Ondracek, Director Business Development
5. PK/PD
modeling
First-in-
humans
Research in
Children
Micro-dose
studies
CHDR, among others, offers
substantial experience with:
• First-in-human studies in
healthy volunteers &
patients
• Research in special
populations such as young
& elderly patients
• Research in patients with
hepatic and/or renal
impairment or patients
from different ethnicity
• Thorough QT-studies, and
bioequivalence experiments
Study Types
6. Innovative Tools for ‘Proof-of-
Pharmacological-Concept’ Studies
• Continuous CSF-Sampling
– CNS-drug concentrations
– τ /ß-profiles, etc
• NeuroCart
– multidimensional CNS-pharmacodynamics
– optimized for CNS-drug effects and PK/PD
– applicable in patients
• Neuroimaging
– resting state fMRI
– PET-imaging
7. Innovative Tools for CNS Studies: NeuroCart
• Cognitive and memory testing
• Electroencephalography
• Saccadic and smooth pursuit eye movement
• Adaptive tracking
• Finger tapping
• Body sway
• Visual analogue scales
• Psychometric questionnaires
• Autonomic function tests (pupillometry, heart rate
variability)
• Polysomnography
• Other CNS function tests like Symbol Digit
Substitution Test, Critical Flicker Fusion, Stroop
conflict task, etc
8. Innovative Tools for CNS Studies: NeuroCart
Features NeuroCart
-scope -neurocognitive functions included*, but also all other
drug-responsive domains (neurophysiological,
neuroendocrine, motor, subjective, etc)
-clinical relevance -functional validity for large number of individual
functions: postural stability, eye-hand coordination,
attention, subjective, etc
-interpretability -simple because each test mainly assess single brain
function
-frequent repeatability -up to 10 times/day or more
-learning/carry-over effects -limited/absent
-dose/concentration responsiveness -extensive PK/PD-relations possible
-experience -extensive across large number of different drugs,
accumulated within same CRO (CHDR)
10. • Electrical Stimulation
– Olofsen and Dahan, 2005
• Pneumatic Pressure
– Polianskis, 2001
• Cold Pressor
– Eckhardt et al. 1998 and Jones et al. 1988
• Thermal stimulation
– Medoc
• Hyperalgesia models
– UV-B
– capsaicin
– thermal grill
Innovative Tools for Pain Studies: PainCart
11. Research Collaboration agreements with:
• Leiden University Medical Center, Leiden
• Free University Medical Center, Amsterdam
• Alzheimer Research Center, Amsterdam
• Academic Medical Center, Amsterdam
• Erasmus Medical Center, Rotterdam
Collaborations: National Collaborations
12. • Collaboration agreements with:
• Seoul National University Hospital
• Kyungpook National University Hospital
• Peking Union Medical College
• Showa University Hospital Tokyo
• Melbourne
• Edinburgh
• University of Bucharest
• Data management system (Promasys)
• Used at >30 locations worldwide
• Including in Korea
• Seoul National University Hospital
• Yonsei University Hospital
• Samsung Medical Center
• ASAN Medical Center
• Kyungpook National University Hospital
• Inje University Pusan Paik Hospital
• Teaching Resource Center for Clinical Pharmacology
Collaborations: International Collaborations